• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Updates, 11-06-2026: General Updates

    11-06-2026 | 10:39 am

    AstraZeneca Pharma India gained approval to market Trastuzumab deruxtecan (Enhertu®) for an expanded indication: first-line treatment of HER2-positive metastatic breast cancer. This development significantly widens the drug's market potential in India.

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited